Orthosilicic Acid (Bioavailable Silica).

Orthosilicic acid polymerises quickly in water and loses absorbability, and choline is the stabiliser used to hold it in the monomeric form. Choline-stabilised orthosilicic acid is therefore a delivery system rather than a second active.

Ascorbate is the cofactor for prolyl and lysyl hydroxylase in collagen synthesis, and orthosilicic acid is the absorbable silicon form associated with initiating collagen and glycosaminoglycan formation. They act at separate points of one build.

Collagen peptides supply building blocks while absorbable silicon is associated with crosslinking and glycosaminoglycan formation in the same tissue. The pairing is standard in skin, hair and nail formulas.

Copper is the cofactor of lysyl oxidase, which crosslinks collagen and elastin fibres once formed. Silicon is associated with the formation end of that sequence, so the two are sequential rather than overlapping.

MSM feeds the sulfur used to form the cystine bridges that stiffen keratin, and silicon is associated with the connective matrix around it. Each supplies a different structural requirement.

Silicon and boron are both studied for the organic matrix that mineral is laid down on rather than for the mineral itself. Orthosilicic acid associates with glycosaminoglycan and collagen formation; boron influences how calcium and magnesium are handled. The pairing is additive at the matrix level and is a formulation convention in structural blends. Human outcome data for the combination is thin, so read it as mechanistic.

Calcium supplies the mineral phase of bone while silicon is associated with the collagenous scaffold that mineral deposits onto. Population work has linked higher dietary silicon intake with bone density measures, which is an association and not a demonstrated cause. Formulators pair them for that division of labour. Neither is known to change the absorption of the other.

Magnesium sits at the hydroxyapatite surface and supports the enzymes that build bone matrix, alongside silicon's association with connective tissue structure. The two are routinely co-formulated in structural mineral products. The rationale is complementary rather than interactive. Nothing indicates one alters the uptake of the other.

Zinc is a cofactor across the enzymes that build structural protein, including those involved in keratin and collagen turnover, and silicon is associated with the same connective tissue compartment. Nail and hair supplement formulations commonly carry both for that reason. A 2025 review of nail supplements names silicon among the ingredients used in this category without concluding on effect size. The combination rationale is mechanistic.

Manganese is the cofactor for glycosyltransferases that assemble proteoglycan chains, the same class of molecule silicon is found associated with in connective tissue. The two therefore act on the same tissue compartment from different angles. Co-formulation is common in joint and skin products. No human trial has isolated the pair.

Biotin is the cofactor for carboxylases involved in fatty acid and amino acid handling that feed keratin production, while silicon is a structural association in hair and nail tissue. Both appear across nail supplement formulations, as catalogued in a 2025 review of that product class. The review describes ingredient use rather than establishing an effect. Regard the pairing as formulation convention with a mechanistic rationale.

Hyaluronic acid is a glycosaminoglycan of the dermal ground substance, the same compartment silicon is associated with. Supplying the polymer directly and supplying a trace element linked to its scaffolding are different points of entry into one tissue. Skin formulations pair them for that reason. The rationale is structural rather than clinical.

Proline and its hydroxylated form make up a large share of the collagen triple helix, so proline supplies substrate where silicon is associated with matrix organisation. The two occupy different steps of the same construction job. Human data on the combination has not been reported. Read it as mechanistic.

Vitamin D3 governs calcium absorption and the signalling that directs mineral to bone, while silicon is associated with the matrix that mineral binds to. Structural formulas carry both on that split rationale. No interaction between the two has been characterised. The claim here is about normal bone structure, not about any condition.

Vitamin K2 carboxylates osteocalcin and matrix Gla protein so they can bind calcium in the bone matrix, and silicon is associated with the collagenous part of that same matrix. Both act on matrix rather than on mineral supply. The pairing is common in bone formulations. No trial has tested the two together in people.

Every third residue of the collagen helix is glycine, so glycine is the most demanded amino acid in matrix synthesis. Silicon sits alongside as a trace element associated with that matrix. The two are substrate and structural associate rather than an interacting pair. Treatment of this as mechanistic is the honest read.

Silicic acid and its oligomers can associate with polyvalent metal cations in solution, and iron is one of the cations described in that chemistry. Whether this changes iron uptake at supplement doses in people has not been characterised. Spacing the two is a cautious formulation habit rather than a demonstrated requirement. Count it as a chemistry-level flag only.